Düsseldorf, Germany-Snibe showcased its latest advancements in diagnostic technology at MEDICA 2024, the world's premier medical trade fair, held from November 11 to 14 in Düsseldorf, Germany. Snibe's booth at Hall 1, Booth 38, was a vibrant hub of engagement throughout the four-day event. This year, Snibe presented its latest advancements and showcased its ongoing commitment to enhancing diagnostic solutions.
_1731489138.png)
A key highlight of Snibe’s showcase was the Biolumi CX10, an advanced integrated analyzer that seamlessly combines immunoassay and biochemistry testing into a single platform. The Biolumi CX10 boasts an impressive throughput of 2000 tests per hour for biochemistry, along with 1000 tests per hour for both immunoassays and ISE. This offers laboratories a highly efficient solution to meet the growing demands for testing.
_1731489139.png)
In addition to the Biolumi CX10, Snibe also highlighted our latest innovations in molecular diagnostics and hemostasis. The Molecision S6 provides precise molecular diagnostics using cutting-edge digital PCR technology, delivering unmatched sensitivity for detection and quantification. Meanwhile, another exciting upcoming product, the Hemolumi H6, captured the attention of global visitors by showcasing a variety of laboratory diagnostic solutions.
_1731489134.png)
As MEDICA 2024 comes to a close, Snibe would like to extend heartfelt gratitude to all visitors, partners, and supporters for their participation and enthusiasm. We eagerly look forward to seeing you at future events as we continue our mission to advance diagnostic technology and improve healthcare worldwide.
_1731489136.png)
Return
